Assessment of Fitbit Charge 4 for sleep stage and heart rate monitoring against polysomnography and during home monitoring in Huntington’s disease

Mar 7, 2024Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Fitbit Charge 4 accuracy for tracking sleep stages and heart rate compared to standard tests at home in Huntington’s disease

AI simplified

Abstract

Fitbit Charge 4 estimated total sleep and wake times in participants with Huntington's disease with intraclass correlations ranging from 0.79 to 0.96 compared to polysomnography.

  • Fitbit detected waking with 68.6 ± 15.5% sensitivity and 93.7 ± 2.5% specificity, indicating reliable identification of wake periods.
  • Rapid eye movement sleep was detected with a sensitivity of 78.7 ± 31.9% and specificity of 95.6 ± 2.3%, suggesting good accuracy.
  • Deep sleep detection had lower sensitivity at 56.4 ± 28.8% but maintained high specificity of 95.0 ± 4.8%.
  • Heart rate measurements from Fitbit were strongly correlated with those from polysomnography, with a mean absolute error of 1.16 ± 0.42 beats/min.
  • Longer sleep and shorter wake times were observed during home monitoring compared to hospital data, while percentage sleep stage times remained consistent.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free